These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 39234749)

  • 21. Serological Evaluation of Gastric Cancer Risk Based on Pepsinogen and Helicobacter pylori Antibody: Relationship to Endoscopic Findings.
    Kotachi T; Ito M; Yoshihara M; Boda T; Kiso M; Masuda K; Matsuo T; Tanaka S; Chayama K
    Digestion; 2017; 95(4):314-318. PubMed ID: 28571035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
    Yakut M; Örmeci N; Erdal H; Keskin O; Karayel Z; Tutkak H; Soykan I
    Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):302-11. PubMed ID: 23137754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of Serological Gastric Biopsy in Different Gastric Mucosal Lesions: an Observational Study.
    Dong Z; Zhang X; Chen X; Zhang J
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31414587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of combined detection of three gastric functions and Helicobacter pylori typing in chronic gastritis and gastric cancer.
    Wang F
    SLAS Technol; 2024 Aug; 29(4):100141. PubMed ID: 38710304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations.
    Miftahussurur M; Waskito LA; Aftab H; Vilaichone RK; Subsomwong P; Nusi IA; Syam AF; Ratanachu-Ek T; Doohan D; Siregar G; Rezkitha YAA; Fauzia KA; Mahachai V; Yamaoka Y
    PLoS One; 2020; 15(4):e0230064. PubMed ID: 32271765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels.
    Yanaoka K; Oka M; Ohata H; Yoshimura N; Deguchi H; Mukoubayashi C; Enomoto S; Inoue I; Iguchi M; Maekita T; Ueda K; Utsunomiya H; Tamai H; Fujishiro M; Iwane M; Takeshita T; Mohara O; Ichinose M
    Int J Cancer; 2009 Dec; 125(11):2697-703. PubMed ID: 19610064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of Helicobacter pylori status and eradication on the serum levels of trefoil factors and pepsinogen test: serum trefoil factor 3 is a stable biomarker.
    Kaise M; Miwa J; Fujimoto A; Tashiro J; Tagami D; Sano H; Ohmoto Y
    Gastric Cancer; 2013 Jul; 16(3):329-37. PubMed ID: 22907485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors.
    Magris R; De Re V; Maiero S; Fornasarig M; Guarnieri G; Caggiari L; Mazzon C; Zanette G; Steffan A; Canzonieri V; Cannizzaro R
    Clin Transl Gastroenterol; 2020 Sep; 11(9):e00238. PubMed ID: 33094954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies.
    Hartleb M; Wandzel P; Waluga M; Matyszczyk B; Bołdys H; Romañczyk T
    Acta Gastroenterol Belg; 2004; 67(4):320-6. PubMed ID: 15727075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of detecting pepsinogen and gastrin-17 levels in serum for pre-cancerous lesion screening in gastric cancer.
    Yu G; Wang GX; Wang HG; Mo FF; Tang BB
    Neoplasma; 2019 Jul; 66(4):637-640. PubMed ID: 31058531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels.
    Kitamura Y; Yoshihara M; Ito M; Boda T; Matsuo T; Kotachi T; Tanaka S; Chayama K
    J Gastroenterol Hepatol; 2015 Oct; 30(10):1473-7. PubMed ID: 25974661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of chronic atrophic gastritis with gastric-specific circulating biomarkers.
    Yu H; Wang H; Pang H; Sun Q; Lu Y; Wang Q; Dong W
    Arab J Gastroenterol; 2024 Feb; 25(1):37-41. PubMed ID: 38220480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests.
    Hamashima C; Sasazuki S; Inoue M; Tsugane S;
    BMC Cancer; 2017 Mar; 17(1):183. PubMed ID: 28279154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy of GastroPanel for the diagnosis of atrophic gastritis.
    McNicholl AG; Forné M; Barrio J; De la Coba C; González B; Rivera R; Esteve M; Fernandez-Bañares F; Madrigal B; Gras-Miralles B; Perez-Aisa A; Viver-Pi-Sunyer JM; Bory F; Rosinach M; Loras C; Esteban C; Santolaria S; Gomollon F; Valle J; Gisbert JP;
    Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):941-8. PubMed ID: 25014624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer].
    Zhang XH; Huang B; Wang JL; Li YH; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):507-11. PubMed ID: 17147114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.
    Sipponen P; Ranta P; Helske T; Kääriäinen I; Mäki T; Linnala A; Suovaniemi O; Alanko A; Härkönen M
    Scand J Gastroenterol; 2002 Jul; 37(7):785-91. PubMed ID: 12190091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
    Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis.
    Nasrollahzadeh D; Aghcheli K; Sotoudeh M; Shakeri R; Persson EC; Islami F; Kamangar F; Abnet CC; Boffetta P; Engstrand L; Dawsey SM; Malekzadeh R; Ye W
    PLoS One; 2011; 6(10):e26957. PubMed ID: 22066020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study.
    Kiso M; Yoshihara M; Ito M; Inoue K; Kato K; Nakajima S; Mabe K; Kobayashi M; Uemura N; Yada T; Oka M; Kawai T; Boda T; Kotachi T; Masuda K; Tanaka S; Chayama K
    Gastric Cancer; 2017 Sep; 20(5):764-771. PubMed ID: 28025702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.